What 8 Analyst Ratings Have To Say About Avidity Biosciences
What 8 Analyst Ratings Have To Say About Avidity Biosciences
關於Avidity Biosciences，8個分析師評級的看法
A comprehensive examination of how financial...Throughout the last three months, 8 analysts have evaluated Avidity Biosciences (NASDAQ:RNA), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，8位分析師對Avidity Biosciences（納斯達克:RNA）進行了評估，提供了從看好到看淡的多樣化意見。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下面的表格提供了他們最近評級的快照，展示了過去30天情緒的變化，並與前幾個月進行了比較。
Analysts have set 12-month price targets for Avidity Biosciences, revealing an average target of $65.75, a high estimate of $78.00, and a low estimate of $59.00. Witnessing a positive shift, the current average has risen by 9.22% from the previous average price target of $60.20.
分析師們爲Avidity Biosciences設定了12個月的價格目標，顯示出平均目標爲65.75美元，最高預計爲78.00美元，最低預計爲59.00美元。隨着積極的變化，目前的平均目標相比之前的60.20美元上漲了9.22%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
A comprehensive examination of how financial...
對金融專家如...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間